Krishna Vaddi - CEO, Director at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
PRLD on Nasdaq
All Insider Reports
All Insider Reports

Krishna Vaddi - trading volume in the past year for Prelude Therapeutics Inc

Holdings reported by Krishna Vaddi for Prelude Therapeutics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2M $1.38M $0.69 Mar 25, 2025 Direct
Common Stock 552K $382K $0.69 Mar 25, 2025 By Trust
Common Stock 143K $98.7K $0.69 Mar 25, 2025 Indirect
Employee Stock Option (right to buy) 496K Feb 4, 2025 Direct Common Stock

Transactions reported by Krishna Vaddi for Prelude Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.